Clark & Stuart Inc’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,400
Closed -$229K 53
2025
Q4
$229K Buy
+1,400
New +$219K 0.16% 46
2025
Q1
Sell
-1,400
Closed -$202K 44
2024
Q4
$202K Buy
+1,400
New +$201K 0.15% 43

Other funds holding RGEN

Clark & Stuart Inc's RGEN Position: Q1 2026 in Review

Clark & Stuart Inc sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,400 shares — an estimated $229K sold.

Clark & Stuart Inc first reported a position in RGEN in Q4 2024 and held it in 2 quarters. The position peaked at $229K in Q4 2025. 445 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Clark & Stuart Inc reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Clark & Stuart Inc sold 1,400 Repligen shares in Q1 2026, an estimated $229K.
  • Clark & Stuart Inc first reported a position in Repligen in Q4 2024 and held it in 2 quarters.
  • Clark & Stuart Inc's Repligen position peaked at $229K in Q4 2025.
  • 445 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Clark & Stuart Inc's 13F filing for Q1 2026, filed 13 Apr 2026.